Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
University of Utah Health, Amyloidosis Program50 North Medical Drive
Salt Lake City, Utah, United States
Email Phone Web
Amyloidosis is a complicated disorder that affects multiple body systems including an individual’s bone marrow, heart, kidneys, nervous system, lungs, skin and gastrointestinal (GI) system. To address the complexity of this disorder, University of Utah offers a multidisciplinary program where patients are evaluated by various amyloidosis specialists from different disciplines over a short period of time. This team of doctors and other medical staff work together to form a customized and comprehensive plan to addresses patient’s needs and desires. The Amyloidosis Program is aimed to not only treat the disease but to improve overall quality of life of the patients also.
The program staff works together with each patient individually to create a treatment plan that best suits their needs. Treatment can include medications, lifestyle changes, chemotherapy, or, if needed, organ transplant.
Healthcare professionals at University of Utah Health specialise in the following areas:
Jose Nativi-Nicolau, MD
Hematology and Oncology:
Tibor Kovacsovics, MD
Josephine D. Abraham, MD, MPH, FASN
Kelsey Barrell, MD
Loyola University Medical CenterLoyola Medicine is a regional Catholic h...
Isabel Morgado, PhDDr. Isabel Morgado is working as a Sci...
David Wolinsky, MDDavid Wolinsky, MD is a graduate of ...
Stacy Kobayashi, RNStacy Kobayashi earned a BS in Nursing f...
Seattle Cancer Care AllianceSeattle Cancer Care Alliance (SCCA) is a...
Amyloidose-Zentrum – Universitätsklinikum HeidelbergThe Amyloidose-Zentrum was founded at th...
Cardiac Amyloidosis Program at Brigham and Women’s HospitalThe Cardiac Amyloidosis Program at Brigh...
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.